Posttransplant Lymphoproliferative Disorder in Pediatric Liver Transplantation

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2679-2681

  Uribe, M ^a   Hunter, B ^a   Alba, A ^a   Calabran L ^a   Flores, L ^a   Soto, P ^a   Herzog, C ^a  

^a HOSPITAL LUIS CALVO MACKENNA   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GANCICLOVIR; MYCOPHENOLIC ACID; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADOLESCENT; ARTICLE; CANCER MORTALITY; CHILD; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FATALITY; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFANT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NODULAR HYPERPLASIA; ORTHOTOPIC TRANSPLANTATION; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS LOAD;

ADOLESCENT; ANTIGENS, VIRAL; CHILD; CHILE; EPSTEIN-BARR VIRUS INFECTIONS; GANCICLOVIR; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TIME FACTORS; VIRAL LOAD;

EID: 68949205628     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.132     Document Type: Article

References (15)

1. Green M., and Webber S. Posttransplantation lymphoproliferative disorders. Pediatr Clin North Am 50 (2003) 1471
2. Newell K., Alonso E., Whitington P., et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Transplantation 62 (1996) 370
3. Cox K., Lawrence-Miyasaki L., Garcia-Kennedy R., et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disease in young children on FK506 after liver transplantation. Transplantation 59 (1995) 524
4. Younes U., McDiarmid S., Martin M., et al. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transpalnt patients. Transplantation 70 (2000) 94
5. Frey N., and Tsai D. The management of posttransplant lymphoproliferative disorder. Med Oncol 24 (2007) 125
6. Uribe M., Buckel E., Ferrario M., et al. Pediatric liver transplantation: ten years of experience in a multicentric program in Chile. Transplant Proc 37 (2005) 3375
7. World Health Organization Classification of Tumours, Harris N.L., Frizzera G., and Knowles D.M. Post-transplant lymphoproliferative disorders. Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues (2001), IARC Press, Lyon 264
8. Jang J.Y., Kim K.M., Lee Y.J., et al. Quantitative Epstein-Barr virus viral load monitoring in pediatric liver transplantation. Transplant Proc 40 (2008) 2546
9. Green M., and Mazariegos G. Persistent detection of Epstein-Barr virus DNA after pediatric liver transplantation: unclear risks and uncertain responses. Liver Transpl 14 (2008) 1077
10. Taylor A.L., Marcus R., and Bradley J.A. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 56 (2005) 155
11. Hurwitz M., Desai D.M., Cox K.L., et al. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Pediatr Transplant 8 (2004) 267
12. Green M. Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation. Am J Transplant 1 (2001) 103
13. Holmes R., and Sokol R. Epstein-Barr virus and post-transplant lymphoproliferative disease. Pediatr Transplant 6 (2002) 456
14. D'antiga L., Del R.M., Mengoli C., et al. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD. Liver Transpl 13 (2007) 343
15. Elstrom R., Andreadis C., Aqui N., et al. Treatment of PTLD with Rituximab or chemotherapy. Am J Transplant 6 (2006) 569